JACC Specialty Journals - JACC: CardioOncology - Preventing Cardiac Damage In Patients Treated For Breast Cancer And Lymphoma: The PROACT Clinical Trial

JACC: CardioOncology - Preventing Cardiac Damage In Patients Treated For Breast Cancer And Lymphoma: The PROACT Clinical Trial

10/15/24 • 2 min

In this episode of the JACC: CardioOncology Podcast, Antonio Cannata discusses the PROACT clinical trial, which investigated the effectiveness of enalapril in preventing cardiac damage in breast cancer and lymphoma patients undergoing anthracycline therapy. Despite neutral results, the conversation delves into the challenges of defining myocardial injury and emphasizes the need for improved risk stratification and innovative trial designs in future research.

Previous Episode

JACC: Clinical Electrophysiology: Overcoming lead penetration failure in left bundle branch pacing

Emile Daoud, MD, Associate Editor of JACC: Clinical Electrophysiology discusses a recently published original research paper on overcoming lead penetration failure in left bundle branch pacing.

Next Episode

undefined - JACC: Cardiovasc Interventions - Failed Thrombus Aspiration and Reduced Myocardial Perfusion in Patients With STEMI and Large Thrombus Burden

JACC: Cardiovasc Interventions - Failed Thrombus Aspiration and Reduced Myocardial Perfusion in Patients With STEMI and Large Thrombus Burden

Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Sung Gyun Ahn, MD, PhD, discuss a recently published original research paper reporting the outcomes of failed thrombus aspiration in patients with STEMI and large thrombus burden.